Clinical trial Recruiting at 1 site Observational Ages 18 and up

Rapid Evacuation and Access of Cerebral Hemorrhage Registry: observing minimally invasive surgery outcomes

Official title: A Prospective, Multicenter, Global Registry Evaluating Minimally Invasive Surgery for the Treatment of Acute Spontaneous Supratentorial Intracerebral Hemorrhage.

Run by Emory University · NCT07651631 · Data updated 2026-11-12

This registry collection tests how minimally invasive brain-bleed procedures work in real patients with acute spontaneous intracerebral hemorrhage.

More Intracerebral Hemorrhage trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2500 (estimated)
SponsorEmory University
Academic / other
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedAugust 12, 2026
Main results expectedJune 2033
Study endsJune 2033
Registry record updatedAugust 26, 2026
Trial IDNCT07651631 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with acute spontaneous supratentorial ICH, hemorrhage volume ≥ 20 mL, treated with minimally invasive surgery within 7 days of onset.

Probably not a fit

Patients with infratentorial hemorrhages, non-MIS management, or comorbidities meeting exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects real-world data on patients with acute spontaneous supratentorial intracerebral hemorrhage who undergo minimally invasive surgical interventions. It aims to quantify outcomes such as functional status and recovery after MIS in the early period following hemorrhage. The study does not assign treatments but records procedures, timing, imaging findings, and outcomes to understand patterns and potential benefits. Eligible patients have hemorrhages of 20 mL or more and receive MIS within seven days, with outcomes analyzed within the registry framework. The investigation is sponsored by Emory University with support from The Marcus Foundation and is conducted at Grady Memorial Hospital in Atlanta, GA.

Why it matters

Potential benefit: If successful, the registry could clarify real-world effectiveness of MIS for ICH and guide future trials and clinical decision-making.

How similar studies have gone: Previous MIS approaches for ICH have shown mixed but growing interest; registry data can help determine real-world effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage
* Hemorrhage volume ≥ 20 mLs
* Minimally invasive surgical intervention performed within 7 days of hemorrhage

Exclusion Criteria:

* Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (\<1 year), as diagnosed with radiographic imaging
* Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum
* Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms
* Last known normal is unknown
* Historical Modified Rankin Score \> 4
* Known life-expectancy of less than 1 year prior to ICH
* DNR or comfort measures only
* Known pregnancy in female subjects
* Inability or unwillingness of subject or legal guardian/representative to give written informed consent within 7 days of initial hospital arrival
* Inability to meet follow up requiremen

Where it's running

  • Grady Memorial Hospital
    Atlanta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.